SHC
Sotera Health Co
NASDAQ: SHC · HEALTHCARE · DIAGNOSTICS & RESEARCH
$15.78
+0.70% today
Updated 2026-05-08
Market cap
$4.47B
P/E ratio
38.22
P/S ratio
3.76x
EPS (TTM)
$0.41
Dividend yield
—
52W range
$11 – $20
Volume
3.3M
WallStSmart proprietary scores
68
out of 100
Grade: B
Buy
Investment rating
7.3
Growth
B+5.8
Quality
C+8.0
Profitability
A4.7
Valuation
C6/9
Piotroski F-Score
Moderate
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →195 stocks currently score above 75
Price targets
Analyst target
$20.12
+27.50%
12-Month target
$8.24
-47.78%
Intrinsic (DCF)
$17.89
Margin of safety
+2.91%
3 Strong Buy5 Buy2 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ ROE 22.70% — strong efficiency
Risks
- Debt/equity 4.14x — high leverage
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.00B | $1.05B | $1.10B | $1.16B | $1.19B |
| Net income | $-233.57M | $51.38M | $44.40M | $77.95M | $26.59M |
| EPS | — | — | — | — | $0.41 |
| Free cash flow | $95.58M | $-362.71M | $45.09M | $149.18M | — |
| Profit margin | -23.27% | 4.90% | 4.03% | 6.70% | 9.91% |
Peer comparison
Smart narrative
Sotera Health Co trades at $15.78. representing a P/E of 38.22x trailing earnings. Our Smart Value Score of 68/100 indicates the stock is good. The company scores 6/9 on the Piotroski F-Score. TTM revenue stands at $1.19B. with profit margins at 9.91%. Our DCF model estimates intrinsic value at $17.89.
Frequently asked questions
What is Sotera Health Co's stock price?
Sotera Health Co (SHC) trades at $15.78.
Is Sotera Health Co overvalued?
Smart Value Score 68/100 (Grade B, Buy). DCF value $17.89.
What is the price target of Sotera Health Co (SHC)?
The analyst target price is $20.12, representing +27.5% upside from the current price of $15.78.
What is the intrinsic value of Sotera Health Co (SHC)?
Based on our DCF model, intrinsic value is $17.89, a +2.9% margin of safety versus $15.78.
What is Sotera Health Co's revenue?
TTM revenue is $1.19B.
Piotroski F-Score?
6/9 — moderate financial health.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio3.76x
ROE22.70%
Beta1.82
50D MA$14.94
200D MA$16.01
Shares out0.29B
Float0.19B
Short ratio—
Avg volume3.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—